136 related articles for article (PubMed ID: 3101712)
1. Abnormalities of lymphocyte subsets and anti-LAV/HTLV-III status in Greek hemophiliacs.
Choremi H; Economidou J; Psarra K; Sidiri E; Mandalaki T; Louizou C; Gialeraki A; Markakis C; Papaevangelou C; Kallinicos G
AIDS Res; 1986; 2(4):271-7. PubMed ID: 3101712
[TBL] [Abstract][Full Text] [Related]
2. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
Abe T
AIDS Res; 1986 Dec; 2 Suppl 1():S141-6. PubMed ID: 3103637
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
Verani P; Mariani G; Mannucci PM; De Rossi G; Nicoletti L; Titti F; Falcione E; Pasqualetti D; Ammassari M; Gringeri A
J Med Virol; 1986 Jun; 19(2):143-9. PubMed ID: 3014059
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
Ikegami N
AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
[TBL] [Abstract][Full Text] [Related]
5. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
Shannon BT; Roach J; Cheek-Luten M; Ruymann FB
Diagn Immunol; 1986; 4(1):37-42. PubMed ID: 3006971
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate. Correlation with T cell subset distribution, antibodies to lymphadenopathy-associated or human T lymphotropic virus, and analysis of the cellular basis of the deficiency.
Smolen JS; Bettelheim P; Köller U; McDougal S; Graninger W; Luger TA; Knapp W; Lechner K
J Clin Invest; 1985 Jun; 75(6):1828-34. PubMed ID: 2989334
[TBL] [Abstract][Full Text] [Related]
7. HTLV-III infection in homosexuals and hemophiliacs in Sweden.
Biberfeld G; Böttiger B; Karlsson A; Sandström E; Morfeldt-Månsson L; Blombäck M; Nilsson IM; Wiechel B; Saxinger C; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4609s-4611s. PubMed ID: 2990693
[TBL] [Abstract][Full Text] [Related]
8. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
[TBL] [Abstract][Full Text] [Related]
9. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P
Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947
[TBL] [Abstract][Full Text] [Related]
10. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
[TBL] [Abstract][Full Text] [Related]
11. HTLV-III serology in hemophilia: relationship with immunologic abnormalities.
Gill JC; Menitove JE; Anderson PR; Casper JT; Devare SG; Wood C; Adair S; Casey J; Scheffel C; Montgomery RR
J Pediatr; 1986 Apr; 108(4):511-6. PubMed ID: 3083075
[TBL] [Abstract][Full Text] [Related]
12. HTLV III antibodies and immunological alterations in hemophilia patients.
Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H
Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759
[TBL] [Abstract][Full Text] [Related]
13. A longitudinal study of patients with hemophilia: immunologic correlates of infection with HTLV-III/LAV and other viruses.
Stein SF; Evatt BL; McDougal JS; Lawrence DN; Holman RC; Ramsey RB; Spira TJ
Blood; 1985 Oct; 66(4):973-9. PubMed ID: 2994784
[TBL] [Abstract][Full Text] [Related]
14. HTLV-III/LAV antibodies and virus in hemophilia patients in Nebraska: survey and initiation of a prospective study.
Volsky DJ; Wu YT; Sinangil F; Goldsmith JC
AIDS Res; 1986 Feb; 2(1):51-61. PubMed ID: 2424467
[TBL] [Abstract][Full Text] [Related]
15. Immune status of Greek patients with beta-thalassemia major negative for anti-HIV.
Choremi H; Sidiri E; Psarra K; Economidou J; Georgiopoulou P; Politi C; Roumeliotou A; Papaevangelou G
Blut; 1987 May; 54(5):267-73. PubMed ID: 3105626
[TBL] [Abstract][Full Text] [Related]
16. Progressive change in lymphocyte distribution and degree of hypergammaglobulinemia with age in children with hemophilia.
Shannon BT; Roach J; Cheek-Luten M; Orosz C; Ruymann FB
J Clin Immunol; 1986 Mar; 6(2):121-9. PubMed ID: 3086364
[TBL] [Abstract][Full Text] [Related]
17. Detection of antibody to LAV/HTLV-III in sera from hemophiliacs in China.
Zeng Y; Fan J; Zhang Q; Wang PC; Tang DJ; Zhon SC; Zheng XW; Liu DP
AIDS Res; 1986 Dec; 2 Suppl 1():S147-9. PubMed ID: 3103638
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
Biagiotti R; Giudizi MG; Almerigogna F; Mazzetti M; Alessi A; Del Prete GF; Rafanelli D; Fiorilli M; Morfini M; Romagnani S
Clin Exp Immunol; 1986 Feb; 63(2):354-8. PubMed ID: 3009063
[TBL] [Abstract][Full Text] [Related]
19. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
Jason J; McDougal JS; Holman RC; Stein SF; Lawrence DN; Nicholson JK; Dixon G; Doxey M; Evatt BL
JAMA; 1985 Jun; 253(23):3409-15. PubMed ID: 2987559
[TBL] [Abstract][Full Text] [Related]
20. Australian hemophiliac recipients of voluntary donor blood products longitudinally evaluated for AIDS. A clinical and laboratory study, 1983-1986.
Garsia RJ; Gatenby PA; Basten A; Kenny DF; Gallagher KJ; Rickard KA; Gust ID; Maskill W
Aust N Z J Med; 1987 Aug; 17(4):371-8. PubMed ID: 2963611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
